IPB

( | )

> Zasady

Pami?tajcie o zasadach.
Znajdziecie je wszystkie klikaj?c na link:

http://www.amazonki.net/noweforum/index.php?showtopic=92

Najwa?niejsze:
-przed zadaniem pytania sprawdzi? w archiwum czy temat nie by? ju? poruszany. Do tego s?u?y funkcja Szukaj.
-postaraj si? wybra? odpowiedni dzia? do tre?ci postu
-
nazwy tematów nieodpowiadaj?ce tre?ci w nich zawartych b?d? zmieniane.
-
Posty piszemy w sposób przemy?lany - to nie jest chat i macie czas na sformu?owanie czytelnej wypowiedzi. Staramy si? pisa? po polsku. Je?li co? chcemy doda?, a nie ma jeszcze do naszego posta komentarza innego u?ytkownika, u?ywamy opcji EDYTUJ


Dzi?kuje bardzo za uszanowanie zasad.


Klikaj?c na poni?szy link znajdziecie archiwalne tematy z dzia?u:LECZENIE

http://www.amazonki.net/forum1/index.php?board=4.0

> Badania kliniczne
V
b.angel
19.02.2010, 22:07
#1


Guru na forum


Zespó? Amazonki NET
4,849
26-06 07
gród nad mleczn?
9
Numer GG: 5536919



grzebi?c dzisiaj troch? w temacie bada? klnicznych znalaz?am na forum wyborczej spis bada? klinicznych firmy roche przeprowadzanych w naszym kraju

osoba, która go tam wklei?a wyszuka?a je na stronie firmy
wklejam za ni? ( wpis by? z wrze?nia 2009)



aktualnie rekrutujace pacjentki - leki Avastin (Bevacizumab),
Herceptyna (Trastuzumab) i Xeloda (Capecitabine)

www.roche-trials.c.../catg10080.html


Klucz do podstawowych warunkow:

*HER2-Positive Early Breast Cancer=dodatni HER2, wczesny rak piersi

*HER2 Positive Metastatic Breast Cancer=dodatni HER2, rak piersi z
przerzutami

*HER2-Negative Metastatic Breast Cancer =ujemny HER2, rak piersi z
przerzutami

*Maintenance Therapy in Patients With HER2-Negative Metastatic
Breast Cancer =terapia podtrzymujaca, pacjentki z ujemnym HER2 i
przerzutami

*Adjuvant Therapy in Triple Negative Breast Cancer= terapia
adjuwantowa, rak potrojnie negatywny

*Metastatic Breast Cancer = rak piersi z przerzutami



Poland

Bialystok
BETH Study: A Study of Avastin (Bevacizumab) in Combination With
Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-
Positive Early Breast Cancer.
Recruiting

Bydgoszcz
A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as
Maintenance Therapy in Patients With HER2-Negative Metastatic Breast
Cancer
Recruiting

Elblag
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in
Triple Negative Breast Cancer.
Recruiting

Gdansk
A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast
Cancer
Recruiting

Gdansk
A Continuation Study of Herceptin (Trastuzumab) in Patients With
Metastatic Breast Cancer
Recruiting

Gliwice
BETH Study: A Study of Avastin (Bevacizumab) in Combination With
Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-
Positive Early Breast Cancer.
Recruiting

Gliwice
A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast
Cancer
Recruiting

Krakow
BETH Study: A Study of Avastin (Bevacizumab) in Combination With
Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-
Positive Early Breast Cancer.
Recruiting

Krakow
A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as
Maintenance Therapy in Patients With HER2-Negative Metastatic Breast
Cancer
Recruiting

Lodz
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in
Triple Negative Breast Cancer.
Recruiting

Lodz
A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast
Cancer
Recruiting

Lublin
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab)
and Docetaxel in Patients With HER2 Positive Metastatic Breast
Cancer.
Recruiting

Lublin
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in
Triple Negative Breast Cancer.
Recruiting

Olsztyn
BETH Study: A Study of Avastin (Bevacizumab) in Combination With
Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-
Positive Early Breast Cancer.
Recruiting

Poznan
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in
Triple Negative Breast Cancer.
Recruiting

Poznan
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab)
and Docetaxel in Patients With HER2 Positive Metastatic Breast
Cancer.
Recruiting

Poznan
A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as
Maintenance Therapy in Patients With HER2-Negative Metastatic Breast
Cancer
Recruiting

Rybnik
BETH Study: A Study of Avastin (Bevacizumab) in Combination With
Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-
Positive Early Breast Cancer.
Recruiting

Szczecin
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab)
and Docetaxel in Patients With HER2 Positive Metastatic Breast
Cancer.
Recruiting

Ul. 28 Czerwca 1956 Nr 194
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in
Triple Negative Breast Cancer.
Recruiting

Ul. 28 Czerwca 1956 Nr 194
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab)
and Docetaxel in Patients With HER2 Positive Metastatic Breast
Cancer.
Recruiting

Warszawa
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab)
and Docetaxel in Patients With HER2 Positive Metastatic Breast
Cancer.
Recruiting

Warszawa
BETH Study: A Study of Avastin (Bevacizumab) in Combination With
Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-
Positive Early Breast Cancer.
Recruiting

Warszawa
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in
Triple Negative Breast Cancer.
Recruiting

Wroclaw
A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as
Maintenance Therapy in Patients With HER2-Negative Metastatic Breast
Cancer
Recruiting



--------------------




.... przewróci?o si?, niech le?y ....
Go to the top of the page
 
+Quote Post


« · Leczenie · »
 

Reply to this topicStart new topic

 

: · ·

· · ·

: 20.12.2014 - 1:09